AlphAIAlphAI — Financial news for AI agents
mlex.comSEP 282 min read$ISRG

Intuitive Surgical asks US appeals court for rehearing after loss in antitrust case

Intuitive Surgical is seeking a rehearing in a US appeals court after a panel revived an antitrust case against it. The company is challenging a decision that could impact its legal and competitive position.

Original reporting
mlex.com
Published Sep 28, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 11:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefRegulation
Primary signal
$ISRG
Bearish
medium confidence
Mentioned
$ISRG
Relevance
6/10
AlphAI data visualization · based on mlex.com
Decision brief

The 30-second read

$ISRGBearishLow
01

Why it matters

The rehearing request signals continued legal challenges that could affect earnings and valuation.

02

Market read

Legal developments are a material risk factor for ISRG and may influence investor sentiment.

03

What to watch

Potential settlement discussions or regulatory changes that could mitigate the antitrust risk.

Relevance 6/10Novelty 6/10Timing: today

Background

Intuitive Surgical is a leading robotic surgery equipment maker facing an antitrust lawsuit.

Company-level read

Ticker impact

$ISRGBearishMedium confidence
Context

Intuitive Surgical filed a petition for rehearing en banc after a panel revived an antitrust case.

Expected impact

likely downside as investors price in potential antitrust risk

Evidence & confidence

First report of a rehearing request; market typically reacts negatively to ongoing antitrust litigation.

Market effects

Sector

May raise scrutiny on the broader medical device sector regarding antitrust exposure.

Regional

Limited to U.S. markets where Intuitive Surgical is listed.

Global

Minimal global impact beyond sector peers.

Counterpoint

What could challenge this read

If the rehearing succeeds, the stock could rebound sharply, presenting a contrarian buying opportunity.

Key entities

  • Company
    Intuitive Surgical

    Manufacturer of the da Vinci surgical system.

  • Legal Body
    U.S. Court of Appeals for the Ninth Circuit

    Court reviewing the antitrust case.

Read at source← All news

Related articles

SEP 30
$ISRGHighAI 8/10

Intuitive receives CE mark for da Vinci 5 cardiac procedures

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci 5 system in cardiac procedures, including coronary artery bypasses and thoracoscopic cardiotomy. The company aims to expand its robotic-assisted cardiac surgery offerings in Europe, with a dedicated team and partnerships with select centers. ISRG previously received FDA clearance for cardiac use in January.

massdevice.com2 min
SEP 29
$ISRGHighAI 8/10

Intuitive Surgical Gains CE Mark for Cardiac Robotics

Intuitive Surgical received CE mark approval for its da Vinci surgical robot to perform cardiac procedures in adults, including minimally invasive coronary artery bypass. This approval allows Intuitive to compete with rivals Medtronic and Johnson & Johnson in the surgical robotics space. The company aims to expand its cardiac surgery offerings globally, following FDA clearance for cardiovascular procedures in January.

mddionline.com3 min
SEP 15
$ISRGHighAI 8/10

Intuitive receives CE mark for transvaginal use of da Vinci SP system

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci SP system for transvaginal gynecological procedures in Europe, expanding its use in women's health. The system, already approved for other surgeries, allows single-incision operations, potentially improving recovery and outcomes. It is also approved in the US, Japan, and Korea.

yahoo.com2 min
SEP 14
$ISRGHigh

Intuitive announces expanded indication for da Vinci SP in Europe

Intuitive (ISRG) received CE mark approval for transvaginal gynecologic procedures using the da Vinci SP system in Europe, expanding its applications. The approval allows for less invasive options and potentially better recovery experiences. The system is already approved in the US, Japan, and Korea for various procedures.

prnewswire.com2 min